For over a decade, we've heard about AI's transformative potential in therapeutics (Tx), but where's the evidence? Has it all been hype? Can AI still revolutionize Tx? Or is there something the AI experts aren't telling us?
First, some facts. The process of Tx development—from early clinical trials to FDA approval—is excruciatingly slow (over 10 years), expensive (over $2B, especially for immunotherapy drugs), and comes with a low probability of success (5% in Immune-Oncology, and similarly
Read More
Health IT & Digital Health-Opinion | Op-Eds | Guest Columns | Analysis, Insights - HIT Consultant
How Clinical Pharmacist-Led Telehealth Models Are Transforming Diabetes Care
Diabetes, a chronic condition affecting millions of Americans, is on the rise. According to the CDC, 15.8% of the U.S. population now lives with diabetes. With over 38 million people managing this complex disease, effective care is essential. Yet, access to diabetes care has become increasingly challenging, especially for underserved communities. The closure of primary care clinics by major retail pharmacy chains has further strained access to care, leaving vulnerable populations without the
Read More
Increasing Participation in Muscular Dystrophy Clinical Trials
Muscular Dystrophy (MD) refers to a group of rare genetic conditions that cause progressive muscle weakness and degeneration in patients. Some forms of MD, such as Duchenne Muscular Dystrophy (DMD), can be life threatening to heart and respiratory functions.
But recent research found that among 3,661 U.S. patients with Muscular Dystrophy, only 33% of those with Duchenne and 12% of those with Becker Muscular Dystrophy - a similar but milder and later-onset MD condition - have previously
Read More
New President – What’s Going to Happen to Healthcare?
High insurance premiums and medical costs don’t discriminate or differentiate based on your political affiliation. Therefore, healthcare should be one of your top priorities for the new administration. As a country we have been passengers passively watching the medical costs increase while the services deteriorate, only reacting when the problem lands on our doorstep.
This is a complex topic with fingers pointing everywhere passing the blame game like a hot potato. In my
Read More
Rethinking Long-Term Care Infection Control for an Aging America
From April to August 2020, 45% of U.S. COVID deaths occurred in long-term care (LTC) facilities, even though LTC residents made up only 0.45% of the population. This stark disparity revealed that nursing homes were particularly vulnerable during the pandemic, with high transmission and fatality rates in these congregate settings. Skilled Nursing Facilities (SNFs), commonly known as nursing homes, represented about 80% of LTC COVID deaths, making them the deadliest place to live during COVID.
Read More
Innovation & Risks: The Double-Edged Sword of Health Technology
The health technology landscape is a rapidly evolving ecosystem where innovation and risk coexist. Developers and manufacturers must balance technological advancements with a rigorous approach to risk management. This entails navigating complex regulatory frameworks, ensuring supply chain security, and prioritizing cybersecurity. By adopting a holistic perspective and proactively mitigating potential risks, health technology companies can drive innovation while safeguarding patient safety and
Read More
Hyperautomation in Healthcare: Transforming IT with Benefits and Risks
Healthcare is navigating an era of unprecedented technological evolution while contending with rising cybersecurity threats and increasing demands on IT systems. Amid these challenges, hyperautomation emerges as a transformative strategy capable to revolutionize operations, enhance security, and drivie efficiency. However, achieving its full potential requires thoughtful implementation and a proactive risk management.
This article explores hyperautomation’s transformative
Read More
The Role of Multimodal Security in Protecting Critical Healthcare Data
Healthcare organizations face an increasingly sophisticated array of threats, including AI-generated attacks like deepfakes. These attacks target critical healthcare data, putting patient safety and institutional integrity at risk. Traditional identity security measures, such as the use of password authentication, while foundational, are no longer sufficient to address these challenges. As biometrics become more pivotal in digital interactions across industries, concerns about accuracy,
Read More
Building Trust in Healthcare Marketing in 2025: The Hidden Ingredient for Successful Campaigns
In the world of healthcare marketing, crafting an effective campaign involves numerous elements: technology, precise audience targeting, budget considerations, timing, objectives, and the coordination of multiple stakeholders. Yet, there is one crucial factor that underpins all these components, one that is often overlooked but essential Is trust. Trust is the invisible thread that binds agencies, vendors, platforms, and clients together. When nurtured, it transforms an ordinary campaign into a
Read More
Open Source in Life Sciences: Balancing Innovation and Compliance
Data science teams in the life sciences industry are experiencing a significant change that will transform how clinical data is analyzed, opening the door to new possibilities for innovation. The transition isn’t happening overnight, but such incremental approaches are necessary to ensure success in such a highly regulated environment.
For decades, SAS was “it” in life sciences. If you wanted to be a data scientist in the industry, you had to know SAS. However, recently there has been a move
Read More
